Olympus medical systems corp.(omsc) was informed that during routine surveillance culturing test by the facility, the subject device repeatedly tested positive for bacteria.On (b)(6) 2017, the subject tested positive for pseudomonas aeruginosa (101cfu/100ml).On (b)(6) 2017, the subject tested positive for pseudomonas aeruginosa (148cfu/100ml) and stenotrophomonas maltophilia (401cfu/100ml).The subject device had been reprocessed using non-olympus automated endoscope reprocessor (soluscope) with peracetic acid.There was no report of patient infection associated with the event.
|